SENTI BIOSCIENCES, INC.

Dynamics Special Purpose Corp. (DYNS), sponsored by Casdin Capital and Foresite Capital, completed its initial public offering in 2021 targeting the biotechnology and pharmaceutical sector. In December 2021, the blank-check company announced a business combination with Senti Biosciences, Inc., a synthetic biology company developing gene circuit-based cell and gene therapies designed to produce smarter, more precise medicines. The transaction subsequently closed, with the combined company listing on Nasdaq under the ticker SNTI. The deal is now reflected as closed in SPAC tracking records. Sign up on SpacDesk for full data on DYNS, Senti Biosciences, and the broader SPAC market.

SPAC Counterparty (1)